EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents

Abhishek Wahi, Priti Jain, Apurba Sinhari, Hemant R Jadhav

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-02 · 397 (2) · 675-702

DOI: 10.1007/s00210-023-02674-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 24.08.2023. Verfasst von Abhishek Wahi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, DPSRU, New Delhi, 1…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 201 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study of epigenetic translational modifications had drawn great interest for the last few decades. These processes play a vital role in many diseases and cancer is one of them. Histone acetyltransferase (HAT) and histone deacetylases (HDACs) are key enzymes involved in the acetylation and deacetylation of histones and ultimately in post-translational modifications. Cancer frequently exhibits epigenetic changes, particularly disruption in the expression and activity of HDACs. It includes the capacity to regulate proliferative signalling, circumvent growth inhibitors, escape cell death, enable replicative immortality, promote angiogenesis, stimulate invasion and metastasis, prevent immunological destruction, and genomic instability. The majority of tumours develop and spread as a result of HDAC dysregulation. As a result, HDAC inhibitors (HDACis) were developed, and they today stand as a very promising therapeutic approach. One of the most well-known and efficient therapies for practically all cancer types is chemotherapy. However, the efficiency and safety of treatment are constrained by higher toxicity. The same has been observed with the synthetic HDACi. Natural products, owing to many advantages over synthetic compounds for cancer treatment have always been a choice for therapy. Hence, naturally available molecules are of particular interest for HDAC inhibition and HDAC has drawn the attention of the research fraternity due to their potential to offer a diverse array of chemical structures and bioactive compounds. This diversity opens up new avenues for exploring less toxic HDAC inhibitors to reduce side effects associated with conventional synthetic inhibitors. The review presents comprehensive details on natural product HDACi, their mechanism of action and their biological effects. Moreover, this review provides a brief discussion on the structure activity relationship of selected natural HDAC inhibitors and their analogues which can guide future research to discover selective, more potent HDACi with minimal toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansHistone Deacetylase InhibitorsHistone DeacetylasesEpigenesis, Genetic

Stichwörter der Autor:innen

CancerEpigeneticHDAC inhibitorsHistone acetyltransferase (HAT)Histone deacetylase (HDAC)Natural productsSmall molecules

Substanzen

Histone Deacetylase InhibitorsHistone DeacetylasesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, DPSRU, New Delhi, 110017, India.
  • Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, DPSRU, New Delhi, 110017, India. pritijain@dpsru.edu.in.
  • Department of Pharmacy, Birla Institute of Technology and Science, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India.

Zitieren

APA

Wahi, A., Jain, P., Sinhari, A., & Jadhav, H. R. (2024). Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(2), 675-702. https://doi.org/10.1007/s00210-023-02674-4

Vancouver

Wahi A, Jain P, Sinhari A, Jadhav HR. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(2):675-702. doi:10.1007/s00210-023-02674-4

BibTeX
@article{Wahi2024,
  author = {Wahi, Abhishek and Jain, Priti and Sinhari, Apurba and Jadhav, Hemant R},
  title = {Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  volume = {397},
  number = {2},
  pages = {675--702},
  doi = {10.1007/s00210-023-02674-4}
}
Kostenlos starten →